{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:20:14Z","timestamp":1758759614018,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.thromres.2024.02.025","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T01:56:43Z","timestamp":1708912603000},"page":"216-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bleeding disorders of unknown cause; the role of physiological anticoagulants"],"prefix":"10.1016","volume":"237","author":[{"given":"Amaury","family":"Monard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floor","family":"Heubel-Moenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2024.02.025_bb0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.10816","article-title":"High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls","volume":"92","author":"Quiroga","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.thromres.2024.02.025_bb0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/hae.13422","article-title":"High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: results from the Vienna bleeding biobank (VIBB)","volume":"24","author":"Gebhart","year":"2018","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.thromres.2024.02.025_bb0015","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/hae.13991","article-title":"Evaluation of thromboelastometry, thrombin generation and plasma clot lysis time in patients with bleeding of unknown cause: a prospective cohort study","volume":"26","author":"Veen","year":"2020","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.thromres.2024.02.025_bb0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/hae.13922","article-title":"Diagnostic work up of patients with increased bleeding tendency","volume":"26","author":"Zegers","year":"2020","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2024.02.025_bb0025","article-title":"Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report","volume":"3","author":"Rodeghiero","year":"2019","journal-title":"Hemasphere"},{"issue":"19","key":"10.1016\/j.thromres.2024.02.025_bb0030","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.2020010038","article-title":"How I treat bleeding disorder of unknown cause","volume":"138","author":"Baker","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2024.02.025_bb0035","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/jth.14529","article-title":"Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause","volume":"17","author":"Hofer","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.02.025_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ijlh.13124","article-title":"Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment","volume":"42","author":"MacDonald","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2024.02.025_bb0045","article-title":"Von Willebrand disease in the Netherlands: the WiN study","volume":"158","author":"Sanders","year":"2014","journal-title":"Ned. Tijdschr. Geneeskd."},{"issue":"5","key":"10.1016\/j.thromres.2024.02.025_bb0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MBC.0000000000000444","article-title":"Laboratory evaluation of patients with undiagnosed bleeding disorders","volume":"27","author":"Alves","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"9","key":"10.1016\/j.thromres.2024.02.025_bb0055","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00277-011-1201-8","article-title":"Thrombin generation in patients with a bleeding tendency of unknown origin","volume":"90","author":"Ay","year":"2011","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2024.02.025_bb0060","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/hae.14174","article-title":"Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management","volume":"26","author":"Thomas","year":"2020","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.thromres.2024.02.025_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12681","article-title":"Fibrinolytic assays in bleeding of unknown cause: improvement in diagnostic yield","volume":"6","author":"Valke","year":"2022","journal-title":"Research and practice in thrombosis and haemostasis."},{"issue":"3","key":"10.1016\/j.thromres.2024.02.025_bb0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-016-2893-6","article-title":"Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause","volume":"96","author":"Gebhart","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2024.02.025_bb0075","unstructured":"Floor. C.J.I. Heubel-Moenen SLNB, Linda Herfs, Lara S. Boerenkamp, Rick J.H. Wetzels, Paul W.M. Verhezen, Patric Machiels, Karyn Megy, Kate Downes, Johan. W.M. Heemskerk, Erik. A.M. Beckers, Yvonne. M.C. Henskens. Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyzer closure time. Submitted."},{"issue":"23","key":"10.1016\/j.thromres.2024.02.025_bb0080","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"Downes","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.02.025_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2024.01.018","article-title":"Activated protein C and free protein S in patients with mild to moderate bleeding disorders","volume":"235","author":"Mehic","year":"2024","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2024.02.025_bb0090","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/hae.14433","article-title":"Thrombomodulin in patients with mild to moderate bleeding tendency","volume":"27","author":"Mehic","year":"2021","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:24Z","timestamp":1758736344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":18,"alternative-id":["S0049384824000665"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.02.025","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding disorders of unknown cause; the role of physiological anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}